Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI |
_version_ | 1797198587694678016 |
---|---|
author | Awwad A. Radwan Fars Alanazi Abdullah Al-Dhfyan |
author_facet | Awwad A. Radwan Fars Alanazi Abdullah Al-Dhfyan |
author_sort | Awwad A. Radwan |
collection | DOAJ |
first_indexed | 2024-04-24T07:02:14Z |
format | Article |
id | doaj.art-9b4c4f482a1e4f92af807a4add907568 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-24T07:02:14Z |
publishDate | 2024-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-9b4c4f482a1e4f92af807a4add9075682024-04-22T05:32:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01194Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluationAwwad A. RadwanFars AlanaziAbdullah Al-Dhfyanhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI |
spellingShingle | Awwad A. Radwan Fars Alanazi Abdullah Al-Dhfyan Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation PLoS ONE |
title | Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation |
title_full | Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation |
title_fullStr | Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation |
title_full_unstemmed | Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation |
title_short | Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation |
title_sort | bioinformatics driven discovery of novel egfr kinase inhibitors as anti cancer therapeutics in silico screening and in vitro evaluation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI |
work_keys_str_mv | AT awwadaradwan bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation AT farsalanazi bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation AT abdullahaldhfyan bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation |